Biotech
$ANIK Anika Reports Strong 3Q11 Sales and Profit Growth
Written by Mike Havrilla — Anika Therapeutics (NASDAQ:ANIK) develops and markets bio-polymer (based on naturally occurring polymer hyaluronic acid / HA) joint health and tissue repair products.
Continue reading...Introducing "How To Trade Options" 50% off Pre-Sale
28 November 2011 – 3:16 am PDT
Comments Off
Exclusive Interview with Mangrove Partners’ Nathaniel August (CLSN)
22 October 2011 – 3:46 am PDT
Comments Off
$RGRX – Key Clinical Data to be Released Week of 10/31/11
22 October 2011 – 3:46 am PDT
Comments Off
Exclusive Interview with Mangrove Partners’ Nathaniel August (CLSN)
21 October 2011 – 3:15 am PDT
Comments Off
29 November 2011 – 3:16 am PDT
Comments Off